Search research articles
Contact Us
Filters
Showing results (161-170 of 312) with videos related to
Page
of 32
Sort By:
European Urology Oncology
|
December 24, 2023
Testosterone Recovery for Relugolix Versus Leuprolide in Men with Advanced Prostate Cancer: Results from the Phase 3 HERO Study
Ronald Tutrone, Fred Saad, Daniel J George, et al.
Eclinicalmedicine
|
August 21, 2025
Impact of treatment suspension on health-related quality of life in the EMBARK trial: a post hoc analysis
Stephen J Freedland, Ugo De Giorgi, Antti Rannikko, et al.
Future Oncology (London, England)
|
February 8, 2023
Efficacy and safety of darolutamide in Black/African-American patients from the phase III ARAMIS study
Neal D Shore, Felipe Cruz, Luke Nordquist, et al.
Prostate Cancer and Prostatic Diseases
|
March 2, 2024
A multidisciplinary approach to address unmet needs in the management of patients with non-metastatic castration-resistant prostate cancer
Neal D Shore, Emmanuel S Antonarakis, Ashley E Ross, et al.
BMC Urology
|
September 8, 2018
Number-needed-to-treat analysis of clinical progression in patients with metastatic castration-resistant prostate cancer in the STRIVE and TERRAIN trials
Neil M Schultz, Neal D Shore, Simon Chowdhury, et al.
BMC Urology
|
October 5, 2018
Correction to: Number-needed-to-treat analysis of clinical progression in patients with metastatic castration-resistant prostate cancer in the STRIVE and TERRAIN trials
Neil M Schultz, Neal D Shore, Simon Chowdhury, et al.
The Journal of Sexual Medicine
|
October 15, 2013
Treatment of LUTS secondary to BPH while preserving sexual function: randomized controlled study of prostatic urethral lift
Kevin T McVary, Steven N Gange, Neal D Shore, et al.
European Urology Oncology
|
June 16, 2019
Impact of Centralizing Care for Genitourinary Malignancies to High-volume Providers: A Systematic Review
Stephen B Williams, Mohamed D Ray-Zack, Hogan K Hudgins, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 22, 2025
Enzalutamide with or without leuprolide in patients with high-risk biochemically recurrent prostate cancer: EMBARK post hoc analysis by age
Neal D Shore, Ugo De Giorgi, Matko Kalac, et al.
JAMA Oncology
|
June 16, 2022
Enzalutamide Monotherapy vs Active Surveillance in Patients With Low-risk or Intermediate-risk Localized Prostate Cancer: The ENACT Randomized Clinical Trial
Neal D Shore, Joseph Renzulli, Neil E Fleshner, et al.
Page
of 32
Search research articles
Search
Showing results (161-170 of 312) with videos related to
Sort By:
Page
of 32
European Urology Oncology
|
December 24, 2023
Testosterone Recovery for Relugolix Versus Leuprolide in Men with Advanced Prostate Cancer: Results from the Phase 3 HERO Study
Ronald Tutrone, Fred Saad, Daniel J George, et al.
Eclinicalmedicine
|
August 21, 2025
Impact of treatment suspension on health-related quality of life in the EMBARK trial: a post hoc analysis
Stephen J Freedland, Ugo De Giorgi, Antti Rannikko, et al.
Future Oncology (London, England)
|
February 8, 2023
Efficacy and safety of darolutamide in Black/African-American patients from the phase III ARAMIS study
Neal D Shore, Felipe Cruz, Luke Nordquist, et al.
Prostate Cancer and Prostatic Diseases
|
March 2, 2024
A multidisciplinary approach to address unmet needs in the management of patients with non-metastatic castration-resistant prostate cancer
Neal D Shore, Emmanuel S Antonarakis, Ashley E Ross, et al.
BMC Urology
|
September 8, 2018
Number-needed-to-treat analysis of clinical progression in patients with metastatic castration-resistant prostate cancer in the STRIVE and TERRAIN trials
Neil M Schultz, Neal D Shore, Simon Chowdhury, et al.
BMC Urology
|
October 5, 2018
Correction to: Number-needed-to-treat analysis of clinical progression in patients with metastatic castration-resistant prostate cancer in the STRIVE and TERRAIN trials
Neil M Schultz, Neal D Shore, Simon Chowdhury, et al.
The Journal of Sexual Medicine
|
October 15, 2013
Treatment of LUTS secondary to BPH while preserving sexual function: randomized controlled study of prostatic urethral lift
Kevin T McVary, Steven N Gange, Neal D Shore, et al.
European Urology Oncology
|
June 16, 2019
Impact of Centralizing Care for Genitourinary Malignancies to High-volume Providers: A Systematic Review
Stephen B Williams, Mohamed D Ray-Zack, Hogan K Hudgins, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 22, 2025
Enzalutamide with or without leuprolide in patients with high-risk biochemically recurrent prostate cancer: EMBARK post hoc analysis by age
Neal D Shore, Ugo De Giorgi, Matko Kalac, et al.
JAMA Oncology
|
June 16, 2022
Enzalutamide Monotherapy vs Active Surveillance in Patients With Low-risk or Intermediate-risk Localized Prostate Cancer: The ENACT Randomized Clinical Trial
Neal D Shore, Joseph Renzulli, Neil E Fleshner, et al.
Page
of 32